Benzinga | Aug 6, 2021 07:04AM EDT

NeoGenomics Q2 Adj. EPS $(0.01) Beats $(0.06) Estimate, Sales $122.00M Beat $118.16M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.06) by 83.33 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $122.00 million which beat the analyst consensus estimate of $118.16 million by 3.25 percent. This is a 40.27 percent increase over sales of $86.98 million the same period last year.